论文部分内容阅读
新诊断2型糖尿病患者84例,随机分为SCT组和MST组各42例;泵组用门冬胰岛素,每日总需量的50%为基础率持续24h输入,可据具体情况调基础率分段,基础率在0.3～2.0μ/h。剩余的50%一般按早餐前20%,午餐前10%～15%,晚餐前15%～20%泵入皮下。MST组用诺和灵R三餐前15min,诺和灵N晚10点皮下注射。结果泵组在低血糖发生率、血糖控制天数和胰岛素量都较常规组少,差异有显著性。结论门冬胰岛素泵给药方式的疗效明显优于MST,可以更快的控制血糖,安全性更高。
84 newly diagnosed type 2 diabetic patients were randomly divided into SCT group and MST group, 42 cases; pump group with insulin aspart, the total daily dose of 50% of the basal rate for 24h input, according to the specific circumstances of the basal rate Segment, the basal rate of 0.3 ~ 2.0μ / h. The remaining 50% is usually 20% before breakfast, 10% ~ 15% before lunch and 15% ~ 20% before dinner. MST group with Norovirus R three meals before 15min, Novolin N subcutaneous injection at 10 o’clock in the evening. Results The pump group had less incidence of hypoglycemia, days of glycemic control and insulin volume than the conventional group, the difference was significant. Conclusion Aspart insulin pump is superior to MST in the way of administration, which can control blood sugar faster and has higher safety.